Mandate

Vinge advises Bridgepoint in conjunction with an investment in FCG

January 25, 2018

Vinge has advised Bridgepoint Development Capital in conjunction with the entry into of a partnership in FCG Holding Sverige AB.

FCG Holding Sverige AB is one of the Nordic region’s leading suppliers of specialist services within risk management, compliance, finance and capital management, financial law and corporate governance, with a focus on the financial sector.

The transaction is conditional upon approval by the Swedish Financial Supervisory Authority.

Vinge’s team primarily consisted of partner Daniel Rosvall together with associates Samra Baytar, Michaela Cronemyr, Christina Odengran and Caroline Krassén. Malin Haag and Carolina Sandell provided advice in connection with the notification to, and approval from, the Swedish Financial Supervisory Authority.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026